Certain Omega-3 Extracts From Marine or Aquatic Biomass and Products Containing the Same; Commission Determination Not To Review an Initial Determination Granting a Joint Motion To Terminate the Investigation With Respect to Respondents Aker Biomarine as, Aker Biomarine Antarctic as, and Aker Biomarine Antarctic USA, Inc. on the Basis of a Settlement Agreement, 3623 [2014-01100]

Download as PDF Federal Register / Vol. 79, No. 14 / Wednesday, January 22, 2014 / Notices The Commission completed and filed its determination in these reviews on January 15, 2014. The views of the Commission are contained in USITC Publication 4445 (January 2014), entitled Hot-Rolled Steel Products from China, India, Indonesia, Taiwan, Thailand, and Ukraine (Inv. Nos. 701– TA–405, 406, & 408 and 731–TA–899– 901 & 906–908 (Second Review)). By order of the Commission. Issued: January 16, 2014. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2014–01169 Filed 1–21–14; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–877] Certain Omega-3 Extracts From Marine or Aquatic Biomass and Products Containing the Same; Commission Determination Not To Review an Initial Determination Granting a Joint Motion To Terminate the Investigation With Respect to Respondents Aker Biomarine as, Aker Biomarine Antarctic as, and Aker Biomarine Antarctic USA, Inc. on the Basis of a Settlement Agreement U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 40) of the presiding administrative law judge (‘‘ALJ’’) granting a joint motion to terminate the investigation with respect to respondents Aker Biomarine AS, Aker Biomarine Antarctic AS, and Aker Biomarine Antarctic USA, Inc. on the basis of a settlement agreement in the above-captioned investigation. FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–3065. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). emcdonald on DSK67QTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:00 Jan 21, 2014 Jkt 232001 The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on April 17, 2013, based on a complaint filed on January 29, 2013, as amended on March 21, 2013, and supplemented on April 1, 2013, on behalf of Neptune Technologies & Bioressources Inc. of ´ Laval, Quebec, Canada and Acasti ´ Pharma Inc., also of Laval, Quebec, Canada (collectively, ‘‘Complainants’’). 78 FR 22898–99 (April 17, 2013). The amended complaint alleged violations of Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the sale for importation, importation, or sale within the United States after importation of certain omega-3 extracts from marine or aquatic biomass and products containing the same by reason of infringement of one or more of claims 1–46 and 94 of U.S. Patent No. 8,278,351 and claim 1 of the U.S. Patent No. 8,383,675. The Commission’s notice of investigation named as respondents Aker BioMarine AS of Oslo, Norway; Aker BioMarine Antarctic USA Inc. of Issaquah, Washington; Aker BioMarine Antarctic AS of Stamsund, Norway; Enzymotec Limited of Industrial Zone K’far Baruch, Israel; Enzymotec USA, Inc. of Morristown, New Jersey; ˚ Olympic Seafood AS of Fosnavag, Norway; Olympic Biotec Ltd. of New Zealand; Avoca, Inc. of Merry Hill, North Carolina; Rimfrost USA, LLC of Merry Hill, North Carolina; and Bioriginal Food & Science Corp. of Saskatoon, Saskatchewan, Canada. On December 13, 2013, Complainants and respondents Aker Biomarine AS, Aker Biomarine Antarctic AS, and Aker Biomarine Antarctic USA, Inc. (collectively, ‘‘the Aker Respondents’’) filed an amended joint motion to terminate the investigation with respect to the Aker Respondents on the basis of a settlement agreement. The motion stated that no other respondent opposed. On December 16, 2013, the Commission investigative attorney filed a response in support of the motion. On December 17, 2013, the ALJ issued the subject ID (Order No. 40), granting Complainants’ motion. After considering the ID and the relevant portions of the record, the Commission has determined not to review the ID. The Commission agrees with the ALJ that the amended joint motion for termination complies with PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 3623 the requirements of Commission rule 210.21 and that the settlement does not adversely affect the public health and welfare, competitive conditions in the U.S. economy, the production of like or directly competitive articles in the United States, and U.S. consumers. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). Dated: January 15, 2014. By order of the Commission. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2014–01100 Filed 1–21–14; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–452 and 731– TA–1129–1130 (Review)] Raw Flexible Magnets From China and Taiwan Determination On the basis of the record 1 developed in the subject five-year reviews, the United States International Trade Commission (Commission) determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)), that revocation of the countervailing duty order on raw flexible magnets from China and the antidumping duty orders on raw flexible magnets from China and Taiwan would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission instituted these reviews on August 1, 2013 (78 FR 46604) and determined on November 20, 2013 that it would conduct expedited reviews (78 FR 73561, December 6, 2013). The Commission completed and filed its determination in these reviews on January 15, 2014. The views of the Commission are contained in USITC Publication 4449 (January 2014), entitled Raw Flexible Magnets from China and Taiwan: Investigation Nos. 701–TA–452 and 731–TA–1129–1130 (Review). Dated: January 15, 2014. 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). E:\FR\FM\22JAN1.SGM 22JAN1

Agencies

[Federal Register Volume 79, Number 14 (Wednesday, January 22, 2014)]
[Notices]
[Page 3623]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01100]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-877]


Certain Omega-3 Extracts From Marine or Aquatic Biomass and 
Products Containing the Same; Commission Determination Not To Review an 
Initial Determination Granting a Joint Motion To Terminate the 
Investigation With Respect to Respondents Aker Biomarine as, Aker 
Biomarine Antarctic as, and Aker Biomarine Antarctic USA, Inc. on the 
Basis of a Settlement Agreement

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 40) of the presiding administrative law judge 
(``ALJ'') granting a joint motion to terminate the investigation with 
respect to respondents Aker Biomarine AS, Aker Biomarine Antarctic AS, 
and Aker Biomarine Antarctic USA, Inc. on the basis of a settlement 
agreement in the above-captioned investigation.

FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on April 17, 2013, based on a complaint filed on January 29, 2013, as 
amended on March 21, 2013, and supplemented on April 1, 2013, on behalf 
of Neptune Technologies & Bioressources Inc. of Laval, Qu[eacute]bec, 
Canada and Acasti Pharma Inc., also of Laval, Qu[eacute]bec, Canada 
(collectively, ``Complainants''). 78 FR 22898-99 (April 17, 2013). The 
amended complaint alleged violations of Section 337 of the Tariff Act 
of 1930, as amended, 19 U.S.C. 1337, in the sale for importation, 
importation, or sale within the United States after importation of 
certain omega-3 extracts from marine or aquatic biomass and products 
containing the same by reason of infringement of one or more of claims 
1-46 and 94 of U.S. Patent No. 8,278,351 and claim 1 of the U.S. Patent 
No. 8,383,675. The Commission's notice of investigation named as 
respondents Aker BioMarine AS of Oslo, Norway; Aker BioMarine Antarctic 
USA Inc. of Issaquah, Washington; Aker BioMarine Antarctic AS of 
Stamsund, Norway; Enzymotec Limited of Industrial Zone K'far Baruch, 
Israel; Enzymotec USA, Inc. of Morristown, New Jersey; Olympic Seafood 
AS of Fosnav[aring]g, Norway; Olympic Biotec Ltd. of New Zealand; 
Avoca, Inc. of Merry Hill, North Carolina; Rimfrost USA, LLC of Merry 
Hill, North Carolina; and Bioriginal Food & Science Corp. of Saskatoon, 
Saskatchewan, Canada.
    On December 13, 2013, Complainants and respondents Aker Biomarine 
AS, Aker Biomarine Antarctic AS, and Aker Biomarine Antarctic USA, Inc. 
(collectively, ``the Aker Respondents'') filed an amended joint motion 
to terminate the investigation with respect to the Aker Respondents on 
the basis of a settlement agreement. The motion stated that no other 
respondent opposed. On December 16, 2013, the Commission investigative 
attorney filed a response in support of the motion. On December 17, 
2013, the ALJ issued the subject ID (Order No. 40), granting 
Complainants' motion.
    After considering the ID and the relevant portions of the record, 
the Commission has determined not to review the ID. The Commission 
agrees with the ALJ that the amended joint motion for termination 
complies with the requirements of Commission rule 210.21 and that the 
settlement does not adversely affect the public health and welfare, 
competitive conditions in the U.S. economy, the production of like or 
directly competitive articles in the United States, and U.S. consumers.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    Dated: January 15, 2014.

    By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2014-01100 Filed 1-21-14; 8:45 am]
BILLING CODE 7020-02-P